Why is Nectar Lifesci. falling/rising?

As of 03-Nov, Nectar Lifescience Ltd's stock price is currently at 14.84, reflecting a decline of 0.78, or 4.99%. The stock has been underperforming recently, having lost 7.31% over the last three days and is currently underperforming its sector by 6.29%. Despite a slight increase of 2.13% over the past week and 4.14% over the past month, the year-to-date return is significantly negative at -61.95%, indicating a substantial decline compared to the previous year. The stock's performance is also characterized by mixed moving averages, being higher than the 20-day and 50-day moving averages but lower than the 5-day, 100-day, and 200-day averages. There is a noted increase in investor participation, with delivery volume rising by 10.04% against the 5-day average, suggesting some interest despite the overall downward trend.
In the broader market context, Nectar Lifescience's recent performance contrasts with the benchmark Sensex, which has shown a slight decline of 0.94% over the past week and a positive return of 3.41% over the past month. While the stock has experienced short-term gains, its long-term performance remains significantly weaker than the benchmark, with a staggering decline of 61.95% year-to-date compared to the Sensex's 7.47% increase. This stark difference highlights the challenges faced by Nectar Lifescience in maintaining investor confidence and market position amidst broader market trends.